Table 2.
Description of the lesion and symptoms at diagnosis.
| Variable | Study eye—n (%) |
|---|---|
| Lesion type | |
| Total | 208 (100%) |
| Classic | 83 (39.9%) |
| Minimally classic | 23 (11.1%) |
| Occult | 71 (34.1%) |
| Other shapes | 12 (5.8%) |
| RAP | 9 (4.3%) |
| IPCV | 3 (1.4%) |
| Unknown | 19 (9.1%) |
| Lesion size | |
| Total | 208 (100%) |
| <1 disk | 38 (18.3%) |
| 1-2 disks | 90 (43.3%) |
| >2 disks | 42 (20.2%) |
| Unknown | 38 (18.3%) |
| Subretinal neovascular membrane location | |
| Total | 208 (100%) |
| Yuxtapapillar | 3 (1.4%) |
| Extrafoveal | 22 (10.6%) |
| Yuxtafoveal | 78 (37.5%) |
| Subfoveal | 104 (50.0%) |
| Subfoveal + Yuxtapapillar | 1 (0.5%) |
| Presence of symptoms at diagnosis | |
| Total | 208 (100%) |
| Yes | 208 (100%) |
| Symptoms at diagnosis | |
| Sudden and progressive loss of VA | 136 (65.4%) |
| Central scotoma | 88 (42.3%) |
| Difficulty to read | 49 (23.6%) |
| Metamorphopsia | 99 (47.6%) |
| Photopsia | 1 (0.5%) |
| Other symptoms | 2 (1.0%) |
| Other symptoms | |
| Total | 2 (100%) |
RAP: retinal angiomatous proliferation; IPCV: idiopathic polypoidal choroidal vasculopathy; VA: visual acuity.